Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Croup. A current perspective.

T P Klassen1

  • 1Department of Pediatrics, University of Alberta, Edmonton, Canada.

Pediatric Clinics of North America
|January 12, 2000
PubMed
Summary
This summary is machine-generated.

Glucocorticoids effectively manage croup in children, reducing hospital admissions. Oral dexamethasone is recommended for its ease of use and cost-effectiveness in treating croup symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

StaR Child Health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials.

Clinical pharmacology and therapeutics·2011
Same author

The effectiveness of glucocorticoids in treating croup: meta-analysis.

The Western journal of medicine·2008
Same author

Oral versus intravenous rehydration for treating dehydration due to gastroenteritis in children.

The Cochrane database of systematic reviews·2006
Same author

Acyclovir for treating varicella in otherwise healthy children and adolescents.

The Cochrane database of systematic reviews·2005
Same author

Manifestations and management of chronic insomnia in adults.

Evidence report/technology assessment (Summary)·2005
Same author

Long term effects of a home visit to prevent childhood injury: three year follow up of a randomized trial.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2005
Same journal

Barriers, Breakthroughs, and the Future of Pediatric Dermatologic Care.

Pediatric clinics of North America·2026
Same journal

Advancing Pediatric Dermatology: Innovations in Care and Access.

Pediatric clinics of North America·2026
Same journal

No Child Left Behind: Advancing Access in Pediatric Dermatology, a 4-Year, Single-Center Experience.

Pediatric clinics of North America·2026
Same journal

Telemedicine and Access to Pediatric Dermatology Care.

Pediatric clinics of North America·2026
Same journal

Inequitable Reimbursement for Pediatric Providers: A Review of Structural Factors that Disincentivize the Care of Children.

Pediatric clinics of North America·2026
Same journal

Medical Photography's Power to Change Medical Care.

Pediatric clinics of North America·2026
See all related articles

Area of Science:

  • Pediatrics
  • Emergency Medicine
  • Pharmacology

Background:

  • Croup management has advanced significantly over the past decade.
  • Glucocorticoid use in croup has been linked to reduced healthcare utilization.

Purpose of the Study:

  • To summarize current evidence on croup management.
  • To provide guidance on the use of glucocorticoids and epinephrine in pediatric croup.

Main Methods:

  • Review of existing evidence on croup management strategies.
  • Analysis of treatment outcomes associated with glucocorticoids and epinephrine.

Main Results:

  • Glucocorticoids are recommended for children with croup exhibiting increased work of breathing.
  • Oral dexamethasone (0.15-0.6 mg/kg) is a preferred glucocorticoid due to accessibility and cost.

Related Experiment Videos

  • L-Epinephrine or racemic epinephrine may be used for moderate to severe croup distress.
  • Mist therapy lacks supporting evidence for croup treatment.
  • Conclusions:

    • Glucocorticoids are a cornerstone of effective croup management.
    • Oral dexamethasone offers a practical and cost-effective treatment option.
    • Further research, including randomized controlled trials, is needed for mist therapy.